AGMB

AgomAb Therapeutics NV AGMB

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$336.96M total
EQT Fund Management S.a r.l.
$66.74M0.0%
Sanofi
$36.12M0.0%
Redmile Group, LLC
$35.49M+1649.7%
Cormorant Asset Management, LP
$32.00M0.0%
TCG Crossover Management, LLC
$26.65M0.0%
FEDERATED HERMES, INC.
$21.00M0.0%
Nantahala Capital Management, LLC
$20.36M+30.7%
Casdin Capital, LLC
$20.12M0.0%
Andera Partners
$19.97M0.0%
FMR LLC
$18.93M0.0%
abrdn plc
$10.99M+19.6%
PERCEPTIVE ADVISORS LLC
$7.79M0.0%
Samsara BioCapital, LLC
$7.79M0.0%
Siren, L.L.C.
$5.34M0.0%
ORBIMED ADVISORS LLC
$2.50MNew
PFIZER INC
$1.04M0.0%
ALPS ADVISORS INC
$648.8KNew
Bellevue Group AG
$639.2K-1.5%
SEVEN GRAND MANAGERS, LLC
$617.8K-76.2%
SECTORAL ASSET MANAGEMENT INC
$564.6K0.0%
Burkehill Global Management, LP
$454.3K0.0%
Quadrature Capital Ltd
$265.6KNew
TWO SIGMA INVESTMENTS, LP
$234.6K+26.9%
HRT FINANCIAL LP
$221.0K-28.0%
GOLDMAN SACHS GROUP INC
$153.2K-67.0%
See all 34 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Loading ratio trend…

AGMB insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About AgomAb Therapeutics NV (AGMB): stock profile, AI score and financials

AgomAb Therapeutics NV (AGMB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AGMB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of AGMB by reported 13-F value include EQT Fund Management S.a r.l., Sanofi, Redmile Group, based on the most recent SEC filings. AGMB trades on the Nasdaq exchange and files with the SEC under CIK 2020932. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AGMB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AgomAb Therapeutics NV directly from SEC EDGAR.

SEC EDGAR: CIK 2020932 →